Document is current

Any future updates will be listed below

Rosuvastatin versus Atorvastatin zur Sekundärprävention bei kardiovaskulären Risikopatienten

Crossref DOI link: https://doi.org/10.1007/s11560-024-00789-0

Published Online: 2024-08-02

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark